Physician profile
Todd Burry
NPI 1215936190
$14,960.54
in general payments reported to CMS, 2019-2025
32 companies · $476 in 2025
The $476 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $395 · 2020: $420 · 2021: $12K · 2022: $693 · 2023: $494 · 2024: $430 · 2025: $476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,375 · Education: $25.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,374.99 |
| Education | $25.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,639.06 | 2020-2021 | |
| Ethicon US, LLC | $1,415.29 | 2019-2025 | Vistaseal, Stratafix, Ethicon |
| Tela Bio, INC. | $1,294.54 | 2020-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Depuy Synthes Sales INC. | $282.82 | 2021-2025 | Matrixrib |
| W. L. Gore & Associates, INC. | $205.36 | 2020-2025 | Gore Synecor Biomaterial, Gore Bio-A Tissue Reinforcement |
| Abbvie INC. | $197.73 | 2021-2025 | |
| Allergan, INC. | $96.79 | 2019-2021 | |
| Csl Behring | $95.28 | 2020-2025 | Kcentra |
| Kci USA, INC. | $75.88 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $63.37 | 2021-2023 | Gattex |
| Polynovo North America LLC | $51.52 | 2024-2025 | Novosorb Btm |
| Zimmer Biomet Holdings, INC. | $49.25 | 2020 | |
| Davol INC. | $48.60 | 2021 | |
| Kerecis Limited | $35.01 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Aroa Biosurgery Incorporated | $31.76 | 2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $31.62 | 2019 | |
| Baxter Healthcare | $30.63 | 2025 | Perclot |
| Aimmune Therapeutics, INC. | $29.70 | 2025 | Zenpep |
| Integra Lifesciences Corporation | $28.51 | 2021 | |
| Acera Surgical, INC. | $27.57 | 2025 | Restrata Wound Matrix |
| Becton, Dickinson and Company | $27.00 | 2019 | |
| Boston Scientific Corporation | $25.81 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $25.74 | 2025 | |
| Lexington Medical, INC. | $23.09 | 2022 | |
| Innocoll Pharmaceuticals Limited | $22.94 | 2021 | |
| Z-Medica, LLC | $21.65 | 2019 | |
| Abbott Laboratories | $17.56 | 2024 | Esprit |
| Melinta Therapeutics, LLC | $14.81 | 2019 | |
| Standard Bariatrics, INC. | $14.05 | 2022 | |
| Shire North American Group INC | $13.24 | 2019 | |
| Thd America, INC. | $13.20 | 2019 | |
| Stryker Corporation | $11.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Burry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.